Lakefront Biotherapeutics (ADR) share price logo

Lakefront Biotherapeutics (ADR)

NASDAQ: LKFT

Small Cap

$28.04

+0.11

(+0.39%)

Live

as on

Lakefront Biotherapeutics (ADR) Stock Performance

as on August 14, 2026 at 3:33 am IST

  • Day's Low

    Day's High

    $27.82
    $28.28
    downward going graph

    0.78%

    Downside

    0.86%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

Lakefront Biotherapeutics (ADR) share price movements today

Previous Close
$27.93
Open
$27.93
Volume
227.5K
Day's Low - High
$27.82 - $28.28

Lakefront Biotherapeutics (ADR) Historical Returns

1 Month Return
-6.28 %
3 Month Return
-0.75 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Lakefront Biotherapeutics (ADR) Stock Fundamentals & Key Indicators

Check Lakefront Biotherapeutics (ADR) market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.9B

EPS (TTM)

-13.24

Dividend Yield

0.00%

PE Ratio (TTM)

3.14

Industry PE ratio

-7.496647058823529

PEG Ratio

0

Return On Equity TTM

16.26%

Lakefront Biotherapeutics (ADR) Stock Valuation

Track how Lakefront Biotherapeutics (ADR) P/E has moved over time to understand its valuation trends.

Lakefront Biotherapeutics (ADR) in the last 5 years

  • Overview

  • Trends

Lowest (35.19x)

June 30, 2026

Industry (-7.50x)

August 13, 2026

Today (3.14x)

August 13, 2026

Highest (35.19x)

June 30, 2026

LowHigh

Today’s Price to Earnings Ratio: 3.14x

Lakefront Biotherapeutics (ADR) vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Lakefront Biotherapeutics (ADR) with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$1.9BNA3.1446.83%NA
BUY$44.0B703.05%NA0.00%NA
BUY$134.2B170.49%30.4935.00%NA
BUY$82.1B27.72%19.7327.87%0.44999999999999996%

Indian Investors' Interest in Lakefront Biotherapeutics (ADR) Stock

Search interest for Lakefront Biotherapeutics (ADR) Stock has decreased by -85% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-85% versus previous 30 day period

Lakefront Biotherapeutics (ADR) Quarterly Profit & Loss

All numbers in Millions USD

Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
81
65
71
900
6
Gross Profit
66
60
60
900
1
Operating Income
-158
-57
-41
758
-63
EBITDA
-
-101
2
560
13
Interest Expense
-
-
-
-
-
Depreciation
-
-
-
-
-
Income Before Tax
-156
-104
-221
783
13
Income Tax Expense
-
0
-17
0
0
Net Income
-165
-105
-202
782
14
Net Profit Margin
-204.60%
-161.97%
-284.02%
86.83%
223.61%

Lakefront Biotherapeutics (ADR) Annual Profit & Loss

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
255
261
288
1,112
Gross Profit
255
261
251
1,082
Operating Income
-131
-88
-188
501
EBITDA
-
-
-
358
Interest Expense
9
1
0
2
Depreciation
65
43
45
55
Income Before Tax
-70
5
-3
300
Income Tax Expense
-
-
-
-18
Net Income
-230
230
77
320
Net Profit Margin
-90.36%
88.31%
26.88%
28.85%

Lakefront Biotherapeutics (ADR) Quarterly Cash Flow

All numbers in Millions USD

Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-105
-202
782
14
Operating Cash Flow
-108
-62
-47
-82
Investing Cash Flow
74
56
72
61
Financing Cash Flow
0
-1
0
0
Change in Cash
-36
-7
23
-21

Lakefront Biotherapeutics (ADR) Annual Cash Flow

All numbers in Millions USD

Dec 2023
Dec 2024
Dec 2025
Net Income
211
74
320
Operating Cash Flow
-405
-320
-257
Investing Cash Flow
-
-
288
Financing Cash Flow
-5
-4
-3
Change in Cash
-339
-104
23

Global Institutional Holdings in Lakefront Biotherapeutics (ADR)

Funds
Holdings
Citadel Advisors Llc
0.19%
ALPS Advisors Inc
0.1%
Madison Avenue Partners, LP
3.76%
NORGES BANK
0.14%
EcoR1 Capital, LLC
2.55%

Insights on Lakefront Biotherapeutics (ADR)

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, LKFT stock has moved up by 6.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 469.1% return, outperforming this stock by 482.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 584.4% return, outperforming this stock by 613.4%

About Lakefront Biotherapeutics (ADR)

Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667, which is in a phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in a phase 1/2 trial in relapsed/refractory non-hodgkin lymphoma; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc. The company was formerly known as Galapagos NV and changed its name to Lakefront Biotherapeutics NV in May 2026. The company was incorporated in 1999 and is headquartered in Mechelen, Belgium.
OrganisationLakefront Biotherapeutics (ADR)
HeadquartersSchaliEnhoevedreef 20 T, Mechelen, Belgium, 2800
IndustryBiotechnology
CEOMr. Henry Gosebruch
E-voting on sharesClick here to vote

Key Management of Lakefront Biotherapeutics (ADR)

Name

Title

Mr. Henry Gosebruch

CEO & Executive Director

Ms. Christina Carlson J.D.

Chief Operating Officer

Marieke Vermeersch

Head of Corporate Communication

Ms. Ellen Van Der Aar

Head of Development

Dr. Jeevan Shetty

Head of Clinical Development Oncology

Ruiz Astigarraga

Head of Manufacturing Cell Therapy

Mr. Aaron L. Cox

Chief Financial Officer

Dr. Glenn Schulman M.P.H., Pharm. D., Pharm.D.

Head of Investor Relations

Mr. Fred W. Blakeslee II

Executive VP & General Counsel

Ms. Tania Philipp

Chief People Officer

FAQs

What is Lakefront Biotherapeutics (ADR) share price today?

Lakefront Biotherapeutics (ADR) share price today is $28.04 as on . Lakefront Biotherapeutics (ADR) share today touched a day high of $28.28 and a low of $27.82.

What is the 52 week high and 52 week low for Lakefront Biotherapeutics (ADR) share?

Lakefront Biotherapeutics (ADR) share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Lakefront Biotherapeutics (ADR) stock price today i.e. is trending at $28.04,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Lakefront Biotherapeutics (ADR)'s market capitalisation today?

Lakefront Biotherapeutics (ADR) market capitalisation is $0.00T as on .

How to invest in Lakefront Biotherapeutics (ADR) Stock (LKFT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Lakefront Biotherapeutics (ADR) on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lakefront Biotherapeutics (ADR) Shares that will get you 0.0535 shares as per Lakefront Biotherapeutics (ADR) share price of $28.04 per share as on August 13, 2026 at 10:03 pm IST.

What is the minimum amount required to buy Lakefront Biotherapeutics (ADR) Stock (LKFT) from India?

Indian investors can start investing in Lakefront Biotherapeutics (ADR) (LKFT) shares with as little as ₹95.43 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹954.30 in Lakefront Biotherapeutics (ADR) stock (as per the Rupee-Dollar exchange rate as on ). Based on Lakefront Biotherapeutics (ADR) share’s latest price of $28.04 as on August 13, 2026 at 10:03 pm IST, you will get 0.3566 shares of Lakefront Biotherapeutics (ADR). Learn more about fractional shares .